Pharmaceutical News and Articles

Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory tri

Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy

For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase before endovascular thrombectomy is

AI Three-Item Severity Score Can ID Eczema From Patient-Uploaded Images

An artificial intelligence (AI) Three-Item Severity (TIS) score can identify eczema-affected areas and severity scores from user-uploaded images, according to a

Swept-Source Anterior Segment OCT Can Help Distinguish Early Childhood Glaucoma

The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study publishe

Standardized Branding of Disposable Vaping Devices Reduces Young People's Interest

Standardizing the color and branding of disposable vaping devices reduces young people s interest in trying them, according to a study published online May 20 i

Want To Live Longer? Stay Sociable, Study Says

FRIDAY, May 23, 2025 Seniors who stay socially engaged are much more likely to have longer lives, a new study says.Social engagement among seniors is associated

Family Link For Postpartum Psychosis Discovered

FRIDAY, May 23, 2025 Women are 10 times more likely to develop postpartum psychosis if they have a sister who experienced the condition after an earlier pregnan

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

FRIDAY, May 23, 2025 A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patient

White House Report Blames Toxins, Food and Screens for Poor Health

FRIDAY, May 23, 2025 A new White House report says today s children are the sickest generation in U.S. history when it comes to chronic disease, and it puts the

U.S. FDA Grants Approval for Jivi (Antihemophilic Factor (Recombinant), PEGylated-aucl) in Pediatric Patients 7 to Under 12 Years of Age With Hemophilia A